FDA drug recalls in 2015
Every FDA drug recall initiated in 2015, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,733 recalls, newest first.
May 21, 2015
Class II · Moderate risk
Labeling: Label Mix-Up: An incorrect book label for Sucrets Sore Throat, Cough & Dry Mouth Honey Lemon lozenges was applied to the underside of the Sucrets Sore Throat & Cough Vapor Cherry lozenges tin.
May 20, 2015
Class II · Moderate risk
Failed Dissolution Specifications: Low out of specification dissolution results.
May 19, 2015
Class III · Low risk
Failed pH Specifications: 12 month stability testing
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 18, 2015
Class II · Moderate risk
Lack of Assurance of Sterility
May 15, 2015
Class II · Moderate risk
Labeling: incorrect or missing lot number and/or expiration date
May 15, 2015
Class II · Moderate risk
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
May 15, 2015
Class II · Moderate risk
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
May 15, 2015
Class II · Moderate risk
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection